383 related articles for article (PubMed ID: 10708732)
21. Inhibitory effect of neuropeptide Y on morphine withdrawal is accompanied by reduced c-fos expression in specific brain regions.
Clausen TR; Møller M; Woldbye DP
J Neurosci Res; 2001 May; 64(4):410-7. PubMed ID: 11340648
[TBL] [Abstract][Full Text] [Related]
22. The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats.
Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
Neurosci Lett; 2016 Mar; 617():201-6. PubMed ID: 26879836
[TBL] [Abstract][Full Text] [Related]
23. The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal.
Rasmussen K; Vandergriff J
Neuropharmacology; 2003 Jan; 44(1):88-92. PubMed ID: 12559125
[TBL] [Abstract][Full Text] [Related]
24. Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.
Almela P; Cerezo M; González-Cuello A; Milanés MV; Laorden ML
Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):293-303. PubMed ID: 17216288
[TBL] [Abstract][Full Text] [Related]
25. Decrease of inhibitory synaptic currents of locus coeruleus neurons via orexin type 1 receptors in the context of naloxone-induced morphine withdrawal.
Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
J Physiol Sci; 2019 Mar; 69(2):281-293. PubMed ID: 30406600
[TBL] [Abstract][Full Text] [Related]
26. Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN.
Benavides M; Laorden ML; García-Borrón JC; Milanés MV
Eur J Neurosci; 2003 Jan; 17(1):103-12. PubMed ID: 12534973
[TBL] [Abstract][Full Text] [Related]
27. Naloxone-precipitated morphine withdrawal elicits increases in c-fos mRNA expression in restricted regions of the infant rat brain.
Maeda T; Kishioka S; Inoue N; Shimizu N; Fukazawa Y; Ozaki M; Yamamoto H
Jpn J Pharmacol; 2002 Nov; 90(3):270-5. PubMed ID: 12499582
[TBL] [Abstract][Full Text] [Related]
28. Local opiate withdrawal in locus coeruleus neurons in vitro.
Ivanov A; Aston-Jones G
J Neurophysiol; 2001 Jun; 85(6):2388-97. PubMed ID: 11387385
[TBL] [Abstract][Full Text] [Related]
29. Noradrenaline release in rat locus coeruleus is regulated by both opioid and alpha(2) -adrenoceptors.
Nakai T; Hayashi M; Ichihara K; Wakabayashi H; Hoshi K
Pharmacol Res; 2002 May; 45(5):407-12. PubMed ID: 12123629
[TBL] [Abstract][Full Text] [Related]
30. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
Benavides M; Laorden ML; Milanés MV
J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
[TBL] [Abstract][Full Text] [Related]
31. Effects of morphine withdrawal on micro-opioid receptor-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate autoradiography in rat brain.
Kirschke C; Schadrack J; Zieglgänsberger W; Spanagel R
Eur J Pharmacol; 2002 Jun; 446(1-3):43-51. PubMed ID: 12098584
[TBL] [Abstract][Full Text] [Related]
32. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat.
Zhang T; Feng Y; Rockhold RW; Ho IK
Life Sci; 1994; 55(2):PL25-31. PubMed ID: 7912397
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats.
Riahi E; Mirzaii-Dizgah I; Karimian SM; Sadeghipour HR; Dehpour AR
Behav Brain Res; 2009 Jan; 196(1):11-4. PubMed ID: 18634832
[TBL] [Abstract][Full Text] [Related]
34. Cerebral glucose metabolism during opioid withdrawal following methylnaloxonium injection into the locus coeruleus.
Kimes AS; Maldonado R; Ambrosio E; Koob GF; London ED
Brain Res; 1998 Dec; 814(1-2):1-12. PubMed ID: 9838021
[TBL] [Abstract][Full Text] [Related]
35. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
Vandergriff J; Rasmussen K
Neuropharmacology; 1999 Feb; 38(2):217-22. PubMed ID: 10218862
[TBL] [Abstract][Full Text] [Related]
36. Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray.
Punch LJ; Self DW; Nestler EJ; Taylor JR
J Neurosci; 1997 Nov; 17(21):8520-7. PubMed ID: 9334424
[TBL] [Abstract][Full Text] [Related]
37. Precipitated kappa-opioid receptor agonist withdrawal increase glutamate in rat locus coeruleus.
Hoshi K; Ma T; Ho IK
Eur J Pharmacol; 1996 Oct; 314(3):301-6. PubMed ID: 8957250
[TBL] [Abstract][Full Text] [Related]
38. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
Navarro-Zaragoza J; Laorden ML; Milanés MV
Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750
[TBL] [Abstract][Full Text] [Related]
39. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
Rasmussen K; Kendrick WT; Kogan JH; Aghajanian GK
Neuropsychopharmacology; 1996 Nov; 15(5):497-505. PubMed ID: 8914123
[TBL] [Abstract][Full Text] [Related]
40. α7 Nicotinic acetylcholine receptors in the central amygdaloid nucleus alter naloxone-induced withdrawal following a single exposure to morphine.
Ishida S; Kawasaki Y; Araki H; Asanuma M; Matsunaga H; Sendo T; Kawasaki H; Gomita Y; Kitamura Y
Psychopharmacology (Berl); 2011 Apr; 214(4):923-31. PubMed ID: 21125398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
